Meatech 3D Ltd (NASDAQ: MITC) opened nearly 10% up in the stock market on Tuesday after announcing to have hit the next milestone in bringing bioprinted meat products to the market.
Meatech printed the world’s biggest cultured steak to date
In a press release this morning, Meatech said it successfully printed a 3.67 oz cultured steak from real, living muscle and fat cells. The achievement takes it a step closer to its ultimate goal of “scaled production of cultivated bioprinted steak”.
According to CEO Sharon Fima, the breakthrough proves that Meatech is headed in the right direction.
Today’s breakthrough is the culmination of over one year’s efforts in our cellular biology and high-throughput tissue engineering processes, as well as our precision bioprinting technology. We believe we have both validated our core technologies and placed ourselves at the forefront of the race to develop high-end, real cell-based cultivated premium meat products.
Meatech’s replacement is better than plant-based alternatives
Meatech’s replacement for the conventional steak is better than plant-based alternatives since it’s made from real, living cultivated muscle and fat cells and not soy or pea protein.
The Israel-headquartered company is committed to improving its advanced bioprinting and tissue engineering technologies to produce cultured meat that mimics the “key characteristics of farm-raised, premium steak.”
At 104 grams, Meatech believes its cultured steak to be the largest produced to date. Founded in 1992, the international technology company has facilities in Israel and Belgium. Meatech debuted on the Nasdaq Stock Exchange in March at a per-share price of $10. The stock is yet to return to its listing price so far.
The post Meatech hits a big milestone in scaled production of cultured meat products appeared first on Invezz.
